Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1016/j.ymthe.2023.11.001 | The state of cell and gene therapy in 2023 |
| https://doi.org/10.1016/j.ymthe.2018.10.017 | Addressing the Value of Gene Therapy and Enhancing Patient Access to Transformative Treatments |
| https://doi.org/10.1016/j.jcyt.2019.04.002 | Current state of U.S. Food and Drug Administration regulation for cellular and gene therapy products: potential cures on the horizon |
| https://doi.org/10.1016/j.omtm.2021.04.001 | Global regulatory progress in delivering on the promise of gene therapies for unmet medical needs |
| https://doi.org/10.1016/j.omtm.2023.101125 | Clinical holds for cell and gene therapy trials: Risks, impact, and lessons learned |
| https://doi.org/10.1038/mt.2015.118 | ASGCT and JSGT Joint Position Statement on Human Genomic Editing |
| https://doi.org/10.1038/s41467-019-10865-y | Human cytomegalovirus evades antibody-mediated immunity through endoplasmic reticulum-associated degradation of the FcRn receptor |
| https://doi.org/10.1111/jvh.13121 | Persistent gamma delta T‐cell dysfunction in chronic HCV infection despite direct‐acting antiviral therapy induced cure |
| https://doi.org/10.1016/j.omtm.2023.05.015 | Medicaid coverage practices for approved gene and cell therapies: Existing barriers and proposed policy solutions |
| https://doi.org/10.1016/j.omtm.2024.101403 | Ensuring patient access to gene therapies for rare diseases: Navigating reimbursement and coverage challenges |
| https://doi.org/10.1016/j.omtm.2024.101386 | Optimizing regulatory frameworks for gene therapies in rare diseases: Challenges and solutions |
| https://doi.org/10.1093/ejo/cjaf011 | Long-term comparison of maxillary protraction with hybrid hyrax-facemask vs. hybrid hyrax-mentoplate protocols using Alt-RAMEC: a 5-year randomized controlled trial |
| https://doi.org/10.1016/j.ymthe.2025.08.029 | The future of gene therapy: Safer vectors, sharper focus |
| https://doi.org/10.1016/j.ymthe.2025.05.006 | The landscape of cell and gene therapy today |
| https://doi.org/10.1016/j.ymthe.2023.07.019 | Implementation of a gene therapy education initiative by the ASGCT and Muhimbili University of Health and Allied Sciences |
| https://doi.org/10.1016/j.jcyt.2025.05.007 | International Call for a 10-Year Moratorium on Heritable Human Genome Editing |
| https://doi.org/10.1016/j.ymthe.2025.12.032 | Response to the FDA’s proposed pathway for individualized genetic therapies |
| https://doi.org/10.1016/j.ymthe.2022.08.009 | Assessing the state of Medicaid coverage for gene and cell therapies |
| https://doi.org/10.1038/mt.2015.228 | An ASGCT Perspective on the National Academies Genome Editing Summit |
| https://doi.org/10.1038/nm0712-1007 | Refocus the Recombinant DNA Advisory Committee |
| https://doi.org/10.1097/brs.0000000000004804 | Can Baseline Disability Predict Outcomes in Adult Spinal Deformity Surgery? |
| https://doi.org/10.1038/mt.2016.25 | A New Induction to the Gene and Cell Therapy Hall Of Fame: Genome Editing |
| https://doi.org/10.1016/j.ymthe.2021.08.017 | ASGCT’s new landscape reports: A comprehensive data resource |
| https://doi.org/10.1038/mtm.2013.3 | Bridging the gap: a second open-access sibling joins the MT family of journals |
| https://doi.org/10.1016/j.ymthe.2023.10.012 | Advancing cell and gene therapies: Key takeaways from ASGCT’s 5th Annual Policy Summit |
| https://doi.org/10.1126/science.287.5459.1751 | Gene Therapist, Heal Thyself |
| https://doi.org/10.1006/mthe.2000.0069 | From the ASGT President |
| https://doi.org/10.15171/bi.2016.09 | Gene therapy for CNS diseases – Krabbe disease |
| https://doi.org/10.1089/hum.2018.29081.con | Consensus Statement of European Societies of Gene and Cell Therapy on the Reported Birth of Genome-Edited Babies in China |
| https://doi.org/10.1038/mt.2010.158 | 2010 Gene Therapy Year in Review |
| https://doi.org/10.1016/j.ymthe.2024.03.015 | Large-scale falsification of research papers risks public trust in biomedical sciences |
| https://doi.org/10.1080/02732173.1982.9981666 | Social and family patterns on the colonial Louisiana frontier |
| https://doi.org/10.1038/mt.2016.154 | Gene and Cell Therapies in Expansion Mode: ASGCT 2016 |
| https://doi.org/10.55083/irjeas.2021.v09i02001 | HANDLING VULNERABLE SCRIPT CODE IN WEB ENGINEERING |
| https://doi.org/10.1016/j.ymthe.2023.08.008 | The Molecular Therapy family of journals continues to lead the field of gene and cell therapy |
| https://doi.org/10.1016/j.ymthe.2024.12.030 | Cutting through the stones: Unlocking therapeutic potential with gene editing tools for primary hyperoxaluria type 1 |
| https://doi.org/10.1016/j.omton.2025.201052 | Confronting cancer’s complexity: Cell and gene therapies in an era of rising incidence |
| https://doi.org/10.1016/j.omtn.2026.102861 | Advancing the science of nucleic acids together |